ALK and neoplasm: Fusion partners are diverse, including TPM3, TPM4, CLTC, and ATIC, and the resultant chimeric proteins mediate constitutive ALK activation, promoting aberrant cellular proliferation and remodeling of the inflammatory tumor microenvironment [42].